Skip to main content

Imaging CRO Industry- A Global and Regional Analysis

 BIS healthcare experts have found imaging CRO to be one of the most rapidly evolving markets. The global market for imaging CRO is predicted to grow at a CAGR of 7.25% during the forecast period 2021-2031. As per BIS research, the imaging CRO comprises the ecosystem of multiple services offered, modalities used, and the target customers who can take strategic decisions with the given insights.

The following report presents the reader with an opportunity to unlock comprehensive insights with respect to the global imaging CRO market and helps in forming well-informed strategic decisions. The market research study also offers a wide perspective of the different types of specialty imaging CROs available in the market and their impact on the biopharmaceutical industry by providing critical insights into the direction of its future expansion.

View Report - https://bisresearch.com/industry-report/imaging-cro-market.html

Market Growth Drivers

  • Continued Growth in R&D Spending
  • Increase in the Annual Number of Clinical Trials with Medical Imaging

Market Challenges

  • High Installation Cost of Medical Imaging Systems
  • Supply Chain and Logistical Challenges

Market Opportunities

  • Increasing Outsourcing Trend Among Pharmaceutical Companies
  • Automation in Imaging CRO Process

Key Companies Profiled

Worldcare Clinical, LLC, LabCorp Drug Development (Laboratory Corporation of America Holdings), IXICO PLC, ICON plc, The Micron Group, Medpace Holdings, Inc., Radiant Sage LLC, Biomedical Systems Corporation (ERT), Bioclinica, Imaging Endpoints LLC, Parexel International Corporation, Wuxi AppTec, Syneos Health, Inc.

Key Questions Answered in this Report:

•    What is the major factor driving the growth of the global imaging CRO market?
•    What are the different types of services offered in the global imaging CRO market?
•    What are the key development strategies implemented by the key players to stand out in this global imaging CRO market?
•    What are the key modalities used by the key companies within the global imaging CRO market?
•    What are the various applications of imaging CRO in different industries?
•    In which phase of the clinical trials, does the imaging CRO services are being utilized the most?
•    How have the strategic collaborations among the key players provided a large service sector within the global imaging CRO market? 
•    Which are the leading companies that are dominating the global imaging CRO market?
•    Based on the end-user type, which industry in the global imaging CRO market is anticipated to witness a massive rise in demand during the forecast period?
•    Which region dominates the global market of imaging CROs?
•    Who are the key players operating in the imaging CRO market in each region?
How is each segment of the global Imaging CRO market expected to grow during the forecast period, and what revenue is expected to be generated by each of these segments by the end of 2031?

Request a Sample - https://bisresearch.com/requestsample?id=1193&type=download


Labels:

Comments

Post a Comment

Popular posts from this blog

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

  Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing   microbiome therapeutics market    is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...
Post a Comment
Read more

Digital PCR Market size,Share, Leading Players, Growth, Development and Demand Forecast to 2032

  Increasing investments in R&D for d-PCR molecular diagnostics is one of the major opportunities in the global digital PCR market. Several biotechnology and life sciences companies are working collaboratively on diagnostic test development and using d-PCR as a therapeutic means for applications in several disease indications to enable efficient diagnosis, treatment selection, and treatment monitoring. The global  digital PCR market   is projected to reach $2,847.8 million by 2032 from $441.2 million in 2021, at a CAGR of 18.73% during the forecast period 2022–2032. The growth in the global digital PCR market is expected to be driven by factors such as the increasing prevalence of infectious and genetic diseases globally, the rising awareness of d-PCR-based diagnostic testing, and the significant number of funding for executing research and development. Impact of COVID-19 The current global digital PCR market comprises kits and assays, system, and reagents and consuma...
Post a Comment
Read more

Radiation Dose Management Market Likely To Increase Size, Shares, And Demand Forecast 2022-2032

  Radiation dose is the amount of radiation absorbed by a patient during a diagnostic imaging procedure. A large dose of radiation can cause tissue damage and increase the risk of developing cancer in later stages of life.The development of on-cloud dose management solutions and the growing initiatives on radiation dose management for pediatric procedures are some of the major opportunities in the global radiation dose management market. Furthermore, some of the key trends going on in the market include the increasing development of imaging modalities with technologies that lower radiation dose, partnerships and strategic business alliances dominating the market, and various collaborations among market players. The global  radiation dose management market   was valued at $212.8 million in 2021 and is anticipated to reach $586.7 million by 2032, witnessing a CAGR of 10.30% during the forecast period 2022–2032. The growth in the global radiation dose management market is ex...
Post a Comment
Read more